{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:22:27Z","timestamp":1789143747234,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Medication-related osteonecrosis of the Jaw (MRONJ) is a serious side effect of bone-modifying agents (BMAs), including bisphosphonates, denosumab, and antiangiogenic drugs. Some dental procedures are recognized as local risk factors for MRONJ. Given the lack of specific guidelines for root canal therapy in patients treated with BMA, this scoping review aimed to investigate the risk of MRONJ associated with failed root canal therapy. Subsequently, a meta-synthesis of expert opinions was performed to identify existing recommendations and pitfalls of root canal therapy in patients at risk of MRONJ.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A review search was conducted in PubMed, Scopus, and Web of Science to answer the PIO question: Is root canal therapy failure associated with an increased risk of developing MRONJ? Subsequently, a meta-synthesis was conducted to analyze guidelines, recommendations, and expert opinions regarding root canal therapy in BMA-treated patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five studies were included. All studies were case reports and case series, except one case-control study. Twenty-three patients who developed MRONJ after root canal therapy failure were analyzed. Also, a case- control study including 65 patients receiving BMAs and 46 patients never treated with BMAs was evaluated. In the last one only 4.8% of patients under BMAs developed MRONJ. The most common BMA used was zoledronate. A total of 223 teeth underwent root canal therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlights the potential risks of root canal therapy failure in BMA-treated patients, emphasizing the need to evaluate treatment appropriateness and risk-benefit ratio carefully.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12903-025-06741-5","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T08:33:51Z","timestamp":1755938031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Endodontic therapy and Medication-related osteonecrosis of the jaw onset: a scoping review and expert opinion-based qualitative meta-synthesis"],"prefix":"10.1186","volume":"25","author":[{"given":"R.","family":"Mauceri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Coppini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. C. A.","family":"Caponio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Zamparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Prati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Campisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"6741_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/ODI.14887","author":"A Bedogni","year":"2024","unstructured":"Bedogni A, Mauceri R, Fusco V, Bertoldo F, Bettini G, Di Fede O, Lo Casto A, Marchetti C, Panzarella V, Saia G, et al. Italian position paper (SIPMO-SICMF) on Medication-Related osteonecrosis of the jaw (MRONJ). Oral Dis. 2024. https:\/\/doi.org\/10.1111\/ODI.14887.","journal-title":"Oral Dis"},{"key":"6741_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-023-02732-6","author":"R Mauceri","year":"2023","unstructured":"Mauceri R, Coppini M, Attanasio M, Bedogni A, Bettini G, Fusco V, Giudice A, Graziani F, Marcian\u00f2 A, Nisi M, et al. MRONJ in breast cancer patients under bone modifying agents for cancer treatment-induced bone loss (CTIBL): a multi-hospital-based case series. BMC Oral Health. 2023. https:\/\/doi.org\/10.1186\/s12903-023-02732-6.","journal-title":"BMC Oral Health"},{"key":"6741_CR3","doi-asserted-by":"publisher","first-page":"1441601","DOI":"10.3389\/FROH.2024.1441601","volume":"5","author":"R Mauceri","year":"2024","unstructured":"Mauceri R, Arduini S, Coppini M, Bazzano M, Trujillo I, Campisi G. Drug assumption and awareness about adverse drug reactions. The right to know. The case of the bone-modyfing agents: a systematic review. Front Oral Health. 2024;5:1441601. https:\/\/doi.org\/10.3389\/FROH.2024.1441601.","journal-title":"Front Oral Health"},{"key":"6741_CR4","doi-asserted-by":"publisher","unstructured":"He L, Sun X, Liu Z, Qiu Y, Niu Y. Pathogenesis and multidisciplinary management of Medication-Related osteonecrosis of the jaw. Int J Oral Sci. 2020;12. https:\/\/doi.org\/10.1038\/S41368-020-00093-2.","DOI":"10.1038\/S41368-020-00093-2"},{"key":"6741_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/IJERPH17165998","volume":"17","author":"G Campisi","year":"2020","unstructured":"Campisi G, Mauceri R, Bertoldo F, Bettini G, Biasotto M, Colella G, Consolo U, Di Fede O, Favia G, Fusco V, et al. Medication-Related osteonecrosis of jaws (MRONJ) prevention and diagnosis: Italian consensus update 2020. Int J Environ Res Public Health. 2020;17:1\u201315. https:\/\/doi.org\/10.3390\/IJERPH17165998.","journal-title":"Int J Environ Res Public Health"},{"key":"6741_CR6","first-page":"38","volume":"36","author":"A Utreja","year":"2013","unstructured":"Utreja A, Almas K, Javed F. Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update. Odontostomatol Trop. 2013;36:38\u201346.","journal-title":"Odontostomatol Trop"},{"key":"6741_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-021-96480-8","author":"S Soutome","year":"2021","unstructured":"Soutome S, Otsuru M, Hayashida S, Murata M, Yanamoto S, Sawada S, Kojima Y, Funahara M, Iwai H, Umeda M, et al. Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients. Sci Rep. 2021. https:\/\/doi.org\/10.1038\/S41598-021-96480-8.","journal-title":"Sci Rep"},{"key":"6741_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/JPER.21-0611","volume":"94","author":"MJ Kwoen","year":"2023","unstructured":"Kwoen MJ, Park JH, Kim KS, Lee JR, Kim JW, Lee H, Lee HJ. Association between periodontal disease, tooth extraction, and medication-related osteonecrosis of the jaw in women receiving bisphosphonates: a national cohort-based study. J Periodontol. 2023;94:98\u2013107. https:\/\/doi.org\/10.1002\/JPER.21-0611.","journal-title":"J Periodontol"},{"key":"6741_CR9","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/CLR.12088","volume":"25","author":"TG Kwon","year":"2014","unstructured":"Kwon TG, Lee CO, Park JW, Choi SY, Rijal G, Shin HI. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment. Clin Oral Implants Res. 2014;25:632\u201340. https:\/\/doi.org\/10.1111\/CLR.12088.","journal-title":"Clin Oral Implants Res"},{"key":"6741_CR10","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1007\/S00520-021-06018-X","volume":"29","author":"H Ikesue","year":"2021","unstructured":"Ikesue H, Mouri M, Tomita H, Hirabatake M, Ikemura M, Muroi N, Yamamoto S, Takenobu T, Tomii K, Kawakita M, et al. Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases. Support Care Cancer. 2021;29:4763\u201372. https:\/\/doi.org\/10.1007\/S00520-021-06018-X.","journal-title":"Support Care Cancer"},{"key":"6741_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/IEJ.12018","volume":"46","author":"AT Moinzadeh","year":"2013","unstructured":"Moinzadeh AT, Shemesh H, Neirynck NAM, Aubert C, Wesselink PR. Bisphosphonates and their clinical implications in endodontic therapy. Int Endod J. 2013;46:391\u20138. https:\/\/doi.org\/10.1111\/IEJ.12018.","journal-title":"Int Endod J"},{"key":"6741_CR12","unstructured":"Dental Extraction as a Risk Factor for Bisphosphonate Related Osteonecrosis of the Jaw in Cancer Patients. An Update - PubMed Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/24073539\/ (accessed on 16 September 2024)."},{"key":"6741_CR13","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jcms.2015.03.039","volume":"43","author":"S Otto","year":"2015","unstructured":"Otto S, Tr\u00f6ltzsch M, Jambrovic V, Panya S, Probst F, Ristow O, Ehrenfeld M, Pautke C. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: a trigger for BRONJ development?? Journal of Cranio-Maxillofacial Surgery. 2015;43:847\u201354. https:\/\/doi.org\/10.1016\/j.jcms.2015.03.039.","journal-title":"Journal of Cranio-Maxillofacial Surgery"},{"key":"6741_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/J.1747-4477.2010.00280.X","volume":"36","author":"A Kyrgidis","year":"2010","unstructured":"Kyrgidis A, Arora A, Lyroudia K, Antoniades K. Root canal therapy for the prevention of osteonecrosis of the jaws: an evidence-based clinical update. Aust Endod J. 2010;36:130\u20133. https:\/\/doi.org\/10.1111\/J.1747-4477.2010.00280.X.","journal-title":"Aust Endod J"},{"key":"6741_CR15","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/ODI.13294","volume":"26","author":"O Nicolatou-Galitis","year":"2020","unstructured":"Nicolatou-Galitis O, Papadopoulou E, Vardas E, Kouri M, Galiti D, Galitis E, Alexiou KE, Tsiklakis K, Ardavanis A, Razis E, et al. Alveolar bone histological necrosis observed prior to extractions in patients, who received bone-Targeting agents. Oral Dis. 2020;26:955\u201366. https:\/\/doi.org\/10.1111\/ODI.13294.","journal-title":"Oral Dis"},{"key":"6741_CR16","unstructured":"Medication-Related Osteonecrosis of the Jaw (MRONJ) Mistaken for Acute Apical Abscess. - PubMed Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/38900463\/ (accessed on 17 September 2024)."},{"key":"6741_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/DJ11070168","author":"M Marques-Ferreira","year":"2023","unstructured":"Marques-Ferreira M, Abrantes AM, Paula A, Laranjo M, Pires AS, Caramelo F, Segura-Egea JJ, Brito A, Carvalho L, Botelho MF, et al. The role of apical periodontitis disease in the development of bisphosphonate-related osteonecrosis of the jaw: an animal study. Dent J (Basel). 2023. https:\/\/doi.org\/10.3390\/DJ11070168.","journal-title":"Dent J (Basel)"},{"key":"6741_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2147\/TCRM.S52630","volume":"9","author":"F Kaptan","year":"2013","unstructured":"Kaptan F, Kazandag MK, Iseri U. Treatment of bisphosphonate related osteonecrosis following root Canal therapy at the 1-Year Follow-up: report of two cases. Ther Clin Risk Manag. 2013;9:477\u201382. https:\/\/doi.org\/10.2147\/TCRM.S52630.","journal-title":"Ther Clin Risk Manag"},{"key":"6741_CR19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/01.DON.0000182737.09980.2C","volume":"31","author":"AP Sarathy","year":"2005","unstructured":"Sarathy AP, Bourgeois SL, Goodell GG. Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment: two case reports. J Endod. 2005;31:759\u201363. https:\/\/doi.org\/10.1097\/01.DON.0000182737.09980.2C.","journal-title":"J Endod"},{"key":"6741_CR20","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1111\/ODI.14449","volume":"29","author":"A Tempesta","year":"2023","unstructured":"Tempesta A, Capodiferro S, Di Nanna S, D\u2019Agostino S, Dolci M, Scarano A, Gambarini G, Maiorano E, Favia G, Limongelli L. Medication-Related osteonecrosis of the jaw triggered by endodontic failure in oncologic patients. Oral Dis. 2023;29:2799\u2013805. https:\/\/doi.org\/10.1111\/ODI.14449.","journal-title":"Oral Dis"},{"key":"6741_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467\u201373. https:\/\/doi.org\/10.7326\/M18-0850.","journal-title":"Ann Intern Med"},{"key":"6741_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/S12874-018-0611-X","author":"Z Munn","year":"2018","unstructured":"Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018. https:\/\/doi.org\/10.1186\/S12874-018-0611-X.","journal-title":"BMC Med Res Methodol"},{"key":"6741_CR23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1146\/ANNUREV-PSYCH-010418-102803","volume":"70","author":"AP Siddaway","year":"2019","unstructured":"Siddaway AP, Wood AM, Hedges LV. How to do a systematic review: A best practice guide for conducting and reporting narrative reviews, Meta-Analyses, and Meta-Syntheses. Annu Rev Psychol. 2019;70:747\u201370. https:\/\/doi.org\/10.1146\/ANNUREV-PSYCH-010418-102803.","journal-title":"Annu Rev Psychol"},{"key":"6741_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/NUR.20176","volume":"30","author":"M Sandelowski","year":"2007","unstructured":"Sandelowski M, Barroso J, Voils CI. Using qualitative metasummary to synthesize qualitative and quantitative descriptive findings. Res Nurs Health. 2007;30:99\u2013111. https:\/\/doi.org\/10.1002\/NUR.20176.","journal-title":"Res Nurs Health"},{"key":"6741_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-8-45","author":"J Thomas","year":"2008","unstructured":"Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008. https:\/\/doi.org\/10.1186\/1471-2288-8-45.","journal-title":"BMC Med Res Methodol"},{"key":"6741_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/J.1365-2648.2005.03380.X","volume":"50","author":"D Walsh","year":"2005","unstructured":"Walsh D, Downe S. Meta-synthesis method for qualitative research: a literature review. J Adv Nurs. 2005;50:204\u201311. https:\/\/doi.org\/10.1111\/J.1365-2648.2005.03380.X.","journal-title":"J Adv Nurs"},{"key":"6741_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/J.JOMS.2010.06.197","author":"L Gallego","year":"2011","unstructured":"Gallego L, Junquera L, Pelaz A, D\u00edaz-Bobes C. Rubber dam clamp trauma during endodontic treatment: a risk factor of Bisphosphonate-Related osteonecrosis of the jaw?? J Oral Maxillofac Surg. 2011. https:\/\/doi.org\/10.1016\/J.JOMS.2010.06.197.","journal-title":"J Oral Maxillofac Surg"},{"key":"6741_CR28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/IEJ.13405","volume":"54","author":"F Zamparini","year":"2021","unstructured":"Zamparini F, Pelliccioni GA, Spinelli A, Gissi DB, Gandolfi MG, Prati C. Root canal treatment of compromised teeth as alternative treatment for patients receiving bisphosphonates: 60-month results of a prospective clinical study. Int Endod J. 2021;54:156\u201371. https:\/\/doi.org\/10.1111\/IEJ.13405.","journal-title":"Int Endod J"},{"key":"6741_CR29","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.joen.2009.07.020","volume":"35","author":"A Hsiao","year":"2009","unstructured":"Hsiao A, Glickman G, He JA. Retrospective clinical and radiographic study on healing of periradicular lesions in patients taking oral bisphosphonates. J Endod. 2009;35:1525\u20138. https:\/\/doi.org\/10.1016\/j.joen.2009.07.020.","journal-title":"J Endod"},{"key":"6741_CR30","doi-asserted-by":"crossref","unstructured":"Sportiello L, La Mantia G, Panzarella V, Colella G, Potenza S, Oteri G, Sottosanti L, Bellavia G, Gaio M, Zinzi A, Morreale I, Parrinello G, Geninatti E, Marrazzo E, Fusco V, Capuano A, Campisi G. Oropharyngeal adverse events to drugs and vaccines: pharmacovigilance data from Italy (2019-2021). Oral Dis. 2025;31(3):993-1005.","DOI":"10.1111\/odi.15145"},{"key":"6741_CR31","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/J.JOMS.2022.02.008","volume":"80","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American association of oral and maxillofacial surgeons\u2019 position paper on medication-related osteonecrosis of the jaws-2022 update. J Oral Maxillofac Surg. 2022;80:920\u201343. https:\/\/doi.org\/10.1016\/J.JOMS.2022.02.008.","journal-title":"J Oral Maxillofac Surg"},{"key":"6741_CR32","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1200\/JCO.19.01186","volume":"37","author":"N Yarom","year":"2019","unstructured":"Yarom N, Shapiro CL, Peterson DE, Van Poznak CH, Bohlke K, Ruggiero SL, Migliorati CA, Khan A, Morrison A, Anderson H, et al. Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical practice guideline. J Clin Oncol. 2019;37:2270\u201390. https:\/\/doi.org\/10.1200\/JCO.19.01186.","journal-title":"J Clin Oncol"},{"key":"6741_CR33","unstructured":"Carolina R, Ferrari AP. October Endodontic Treatment of Odontogenic Infection in a Patient at Risk of Medication-Related Osteonecrosis of the Jaw: A Case Report and Review of Treatment Criteria - PubMed Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/37358587\/ (accessed on 24 2024)."},{"key":"6741_CR34","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1007\/S00784-023-04938-Y","volume":"27","author":"I L\u00f3pez-Valverde","year":"2023","unstructured":"L\u00f3pez-Valverde I, Vignoletti F, Vignoletti G, Martin C, Sanz M. Long-term tooth survival and success following primary root canal treatment: a 5- to 37-year retrospective observation. Clin Oral Investig. 2023;27:3233\u201344. https:\/\/doi.org\/10.1007\/S00784-023-04938-Y.","journal-title":"Clin Oral Investig"},{"key":"6741_CR35","doi-asserted-by":"publisher","first-page":"232","DOI":"10.15537\/SMJ.2018.3.20923","volume":"39","author":"MK Alrahabi","year":"2018","unstructured":"Alrahabi MK, Ghabbani HM. Clinical impact of bisphosphonates in root canal therapy. Saudi Med J. 2018;39:232\u20138. https:\/\/doi.org\/10.15537\/SMJ.2018.3.20923.","journal-title":"Saudi Med J"},{"key":"6741_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS15225366","volume":"15","author":"ES Lee","year":"2023","unstructured":"Lee ES, Tsai MC, Lee JX, Wong C, Cheng YN, Liu AC, Liang YF, Fang CY, Wu CY, Lee IT. Bisphosphonates and their connection to dental procedures: exploring bisphosphonate-related osteonecrosis of the jaws. Cancers (Basel). 2023;15: 5366. https:\/\/doi.org\/10.3390\/CANCERS15225366.","journal-title":"Cancers (Basel)"},{"key":"6741_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/J.ORALONCOLOGY.2024.106689","author":"R Mauceri","year":"2024","unstructured":"Mauceri R, Coppini M, P\u00e9rez-Say\u00e1ns M, Toro C, Vitagliano R, Colella G, Rodolico V, Campisi G. Challenges in the diagnosis of oral squamous cell carcinoma mimicking medication-related osteonecrosis of the jaws: a multi-hospital-based case series. Oral Oncol. 2024. https:\/\/doi.org\/10.1016\/J.ORALONCOLOGY.2024.106689.","journal-title":"Oral Oncol"},{"key":"6741_CR38","doi-asserted-by":"publisher","unstructured":"Wong I, Ton A, Cassidy AJ, Fozzard N, Sharma LA, Love RM, Sharma A. A retrospective study on the prognostic factors and success, survival, and failure outcomes of treated Endodontic-periodontal lesions. Clin Exp Dent Res. 2024;10. https:\/\/doi.org\/10.1002\/CRE2.848.","DOI":"10.1002\/CRE2.848"},{"key":"6741_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/S12903-024-03974-8","author":"YE Jang","year":"2024","unstructured":"Jang YE, Kim Y, Kim SY, Kim BS. Predicting early endodontic treatment failure following primary root canal treatment. BMC Oral Health. 2024. https:\/\/doi.org\/10.1186\/S12903-024-03974-8.","journal-title":"BMC Oral Health"},{"key":"6741_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/S12903-016-0163-6","author":"\u00d6 Dereci","year":"2016","unstructured":"Dereci \u00d6, Orhan EO, Irmak \u00d6, Ay S. The effect of the duration of intravenous zolendronate medication on the success of non-surgical endodontic therapy: a retrospective study. BMC Oral Health. 2016. https:\/\/doi.org\/10.1186\/S12903-016-0163-6.","journal-title":"BMC Oral Health"},{"key":"6741_CR41","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/ADJ.12648","volume":"63","author":"A Khominsky","year":"2018","unstructured":"Khominsky A, Lim MAWT. Spontaneous medication-related osteonecrosis of the jaw; two case reports and a systematic review. Aust Dent J. 2018;63:441\u201354. https:\/\/doi.org\/10.1111\/ADJ.12648.","journal-title":"Aust Dent J"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-06741-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-025-06741-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-06741-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:39:07Z","timestamp":1781613547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12903-025-06741-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6741"],"URL":"https:\/\/doi.org\/10.1186\/s12903-025-06741-5","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author names and surnames in Reference 30 was corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1362"}}